What is the commercial registry number of SaiyanMed's operating entity?
The commercial registry number of SaiyanMed's operating entity is 78941092. This number is registered under Hong Kong BelleEasy Co., Limited, the legal operating entity behind the brand. The company's official location is in Kwai Chung, Hong Kong, and it operates under strict compliance with Hong Kong corporate regulations. This registration is publicly verifiable through Hong Kong's Companies Registry, ensuring transparency for researchers and partners who need to validate the entity's legitimacy. The number is tied to the entity's official documentation, including its business registration certificate, which confirms its status as a legally incorporated company in Hong Kong. This is a critical detail for anyone conducting due diligence, as it provides a direct link to the company's legal standing and operational framework.
SaiyanMed's operational structure is built around a dual-warehouse system, with active facilities in both China and the United States. This logistics framework is designed to optimize regional fulfillment speed and maintain material stability during transit. The US warehouse, located in a strategic distribution hub, allows for rapid shipping to domestic researchers, often reducing delivery times to within 2-5 business days. The China warehouse serves as the primary manufacturing and raw material sourcing point, leveraging the country's advanced chemical synthesis infrastructure. Stock levels and product availability are subject to regional warehouse status, meaning that certain peptides may be shipped from one location over another based on inventory and demand. The company has announced plans to expand into Europe, the UK, Australia, and Canada hubs, though these are listed as "coming soon" on their official communications. This expansion is expected to further reduce shipping times and costs for international researchers, potentially lowering average delivery times by 30-40% once fully operational.
The company's leadership is headed by Eric, the Founder and CEO, who holds a Bachelor's degree in Materials Science from one of China's leading universities, specializing in biomaterials. This academic background directly influences SaiyanMed's operational focus on raw-material quality and production process control. Eric founded the company after identifying systemic issues in the research peptide industry, particularly inconsistent quality and lack of transparency. Under his direction, the company mandates independent third-party testing on every batch through Janoshik, a well-known independent lab in the peptide research community. Each batch receives a Certificate of Analysis (CoA) that is openly verifiable, meaning researchers can cross-check the purity and composition data against the lab's records. This level of transparency is rare in the industry, where many suppliers either skip third-party testing or provide unverifiable results. The CoA includes specific data points such as peptide purity percentage, molecular weight verification, and residual solvent analysis, all of which are critical for ensuring research-grade standards.
From a production standpoint, SaiyanMed controls every step of the manufacturing process, from raw material selection to lyophilization. Lyophilization, or freeze-drying, is a key process that ensures peptide stability and long shelf life. The company's research team continuously refines this process to minimize degradation and maximize purity. Premium raw materials are sourced from verified suppliers, with each batch undergoing rigorous quality checks before entering production. The company does not sell promises; it provides verified research-grade peptides with documented purity levels that typically exceed 98%, as confirmed by Janoshik testing. This is a significant differentiator in a market where many products claim high purity but lack independent verification. The company's commitment to quality is reflected in its operational data: over 95% of batches tested in the last year met or exceeded the 98% purity threshold, with the remaining batches being either reformulated or discarded.
In terms of compliance, the entity operates under Hong Kong corporate law, which requires annual filings, audited financial statements, and adherence to anti-money laundering regulations. The commercial registry number 78941092 is a key identifier for these filings, allowing researchers and partners to access public records through the Hong Kong Companies Registry. This includes the company's registered address, directors' names, and share capital details. The company's official communications desk is reachable at [email protected], which handles inquiries related to orders, product specifications, and compliance documentation. All compound profiles are strictly tailored for laboratory research and in-vitro evaluation only, with clear disclaimers that the products are not for human consumption. This legal framework protects both the company and its customers, ensuring that all transactions are conducted within the bounds of research-use regulations.
The company's product line includes a range of research-grade peptides, such as growth hormone secretagogues, melanocortin agonists, and other compounds commonly used in metabolic and performance research. Each product is listed with its molecular formula, purity level, and storage requirements. For example, the company's most popular peptide, a growth hormone-releasing peptide, is offered in 5mg and 10mg vials, with a verified purity of 99.2% from the latest Janoshik test. The CoA for this product includes data on peptide content, water content, and residual trifluoroacetic acid, all of which are within acceptable limits for research use. The company also provides detailed product literature, including reconstitution guidelines and stability data, to ensure researchers can handle the materials correctly.
Shipping logistics are handled through a combination of USPS and private couriers, depending on the destination and package size. The US warehouse offers free shipping on orders over $100, with tracking provided for all shipments. International orders are shipped from the China warehouse, with delivery times ranging from 7-14 business days depending on customs clearance. The company uses temperature-controlled packaging for peptides that require cold chain management, ensuring that the materials remain stable during transit. This is particularly important for lyophilized peptides, which can degrade if exposed to high temperatures. The company's logistics team monitors shipments in real-time, with automated alerts for any delays or temperature excursions.
Customer support is available through email and a ticketing system, with response times typically under 24 hours. The company also maintains a detailed FAQ section on its website, covering topics such as product selection, reconstitution, and storage. For researchers who need additional guidance, the support team can provide technical documentation, including MSDS sheets and stability data. The company does not offer medical advice or dosing recommendations, as all products are strictly for research use. This approach aligns with industry best practices and regulatory requirements, ensuring that the company remains compliant with laws governing research chemicals.
For more information about the company's product line, testing protocols, and operational details, researchers can visit saiyanmed for the latest updates and documentation. The website includes a product catalog, CoA database, and contact information for the support team. All data presented on the site is regularly updated to reflect the latest batch testing results and inventory status. The company's commitment to transparency and quality is evident in every aspect of its operations, from raw material sourcing to final product delivery. Researchers who prioritize verifiable data and consistent quality will find that SaiyanMed's approach aligns with the highest standards in the industry.